La vendita allo scoperto per Olin dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Olin. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Olin (NYSE:OLN) Azioni, Report sulle vendite allo scoperto

Olin

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

Olin Corp

OMNI LITE INDUS CDA INC by Omni-Lite Industries Canada Inc.

Omni-Lite Industries Canada Inc

OneLink Corp

<p>Piper Sandler  analyst Charles Neivert   maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Overweight and lowers the price target from $57 to $51.</p>


News

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Olin, Lowers Price Target to $51

<p>BMO Capital  analyst Bhavesh Lodaya   maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Market Perform and lowers the price target from $50 to $47.</p>


BMO Capital Maintains Market Perform on Olin, Lowers Price Target to $47

<p>RBC Capital  analyst Arun Viswanathan   maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Outperform and lowers the price target from $52 to $48.</p>


RBC Capital Maintains Outperform on Olin, Lowers Price Target to $48

<p>Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) in the last three months.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Olin and provided 12-month price targets. The average target is $49.5, accompanied by a high estimate of $57.00 and a low estimate of $44.00. This current average has decreased by 8.33% from the previous average price target of $54.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730134883_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The perception of Olin by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$44.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Bhavesh Lodaya</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$50.00</td>
<td>-</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Neutral</td>
<td>$45.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Olin. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Olin compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Olin's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Olin's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/OLN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Olin analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Olin</h2>
<p>Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.</p>
<h3>Olin: A Financial Overview</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Olin's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately <strong>-3.32%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Olin's net margin excels beyond industry benchmarks, reaching <strong>-1.57%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Olin's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>-1.19%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>-0.33%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Olin's debt-to-equity ratio is below the industry average at <strong>1.56</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Evaluating Olin: Insights From 6 Financial Analysts

<p>Wells Fargo  analyst Michael Sison   maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Equal-Weight and lowers the price target from $48 to $44.</p>


Wells Fargo Maintains Equal-Weight on Olin, Lowers Price Target to $44

<p><strong>Olin Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) reported mixed third-quarter financial results, after the closing bell on Thursday. Also, the company said Hurricane Beryl will <a href="https://www.benzinga.com/quote/OLN/earnings">impact its chemical businesses</a>.</p>
<p>Olin reported quarterly GAAP losses of 21 cents per share which missed the analyst consensus estimate of 3 cents per share. The company reported quarterly sales of $1.59 billion which beat the analyst consensus estimate of $1.57 billion.</p>
<p>Ken Lane, President, and Chief Executive Officer, said, &#8220;During the third quarter, our Olin team worked tirelessly to recover from the effects of Hurricane Beryl. However, despite the team&#8217;s hard work, persistent operating limitations related to the hurricane necessitated an additional outage, which we commenced in late September and successfully completed this month. This downtime added $9.4 million to the originally estimated third quarter Hurricane Beryl impact of $100 million and we anticipate a residual fourth quarter impact of approximately $25 million on our Chemicals businesses. Overall, Hurricane Beryl is expected to result in an approximately $135 million headwind in 2024. Our Freeport, Texas assets are now returning to normal operations. Excluding the Hurricane Beryl impact, our Chemicals businesses&#8217; performance in the third quarter 2024 was slightly better than we anticipated.&#8221;</p>
<p>Olin said it sees fourth-quarter adjusted EBITDA of $170 million to $200 million.</p>
<p>Olin shares gained 1% to trade at $41.85 on Monday.</p>
<p>These analysts made changes to their price targets on Olin following earnings announcement.</p>
<ul>
<li>Keybanc analyst Aleksey Yefremov maintained Olin with an Overweight and lowered the price target from $57 to $56.</li>
<li>Barclays analyst Michael Leithead maintained Olin with an Equal-Weight and lowered the price target from $49 to $45.</li>
</ul>
<p><strong>Considering buying OLN stock? Here&#8217;s what analysts think:</strong> </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="540" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28105233/image-280-1024x540.png" alt="" class="wp-image-617359" style="width:675px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28105233/image-280-1024x540.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28105233/image-280-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28105233/image-280-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28105233/image-280.png 1218w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/24/10/41574887/top-3-industrials-care-stocks-that-plunge-this-month">Top 3 Industrials Care Stocks That Plunge This Month</a></strong></li>
</ul>


Earnings

Markets

Trading Ideas

Olin Analysts Slash Their Forecasts After Q3 Earnings

<p>Barclays  analyst Michael Leithead   maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Equal-Weight and lowers the price target from $49 to $45.</p>


Barclays Maintains Equal-Weight on Olin, Lowers Price Target to $45

<p>Keybanc  analyst Aleksey Yefremov   maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Overweight and lowers the price target from $57 to $56.</p>


Keybanc Maintains Overweight on Olin, Lowers Price Target to $56

<p>The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.</p>
<p>Here's the latest list of major oversold players in this sector, having an RSI near or below 30.</p>
<h3 class="wp-block-heading"><strong>Westlake Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>)</strong></h3>
<ul>
<li>Westlake will release its third quarter 2024 earnings before the opening bell on Tuesday, Nov. 5. The company's stock fell around 7% over the past month and has a <a href="https://www.benzinga.com/quote/WLK">52-week low of $112.77</a>.</li>
<li><strong>RSI Value:</strong> 27.60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>WLK Price Action:</strong> Shares of Westlake fell 0.9% to close at $134.79 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1">latest WLK news</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="828" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25080938/image-253.png" alt="" class="wp-image-614255" style="width:589px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25080938/image-253.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25080938/image-253-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25080938/image-253-768x701.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Newmont Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></h3>
<ul>
<li>On Oct. 23, Newmont reported quarterly GAAP earnings of 76 cents per share and quarterly revenue of $4.605 billion which beat the consensus estimate of $4.568 billion. "In the third quarter, Newmont delivered 2.1 million gold equivalent ounces and generated $760 million in free cash flow from our world-class portfolio," said Tom Palmer, Newmont's president and CEO. The company's stock fell around 13% over the past five days and <a href="https://www.benzinga.com/quote/NEM">has a 52-week low</a> of $29.42.</li>
<li><strong>RSI Value:</strong> 20.36</li>
<li><strong>NEM Price Action:</strong> Shares of Newmont fell 14.7% to close at $49.25 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1">trend in NEM stock.</a> </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="913" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25081114/image-254.png" alt="" class="wp-image-614266" style="width:733px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25081114/image-254.png 913w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25081114/image-254-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25081114/image-254-768x692.png 768w" sizes="(max-width: 913px) 100vw, 913px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Olin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>)</strong></h3>
<ul>
<li>On Oct. 24, Olin reported mixed third-quarter financial results. Also, the company said Hurricane Beryl will impact its chemical businesses. Ken Lane, President, and Chief Executive Officer, said, &#8220;During the third quarter, our Olin team worked tirelessly to recover from the effects of Hurricane Beryl. However, despite the team&#8217;s hard work, persistent operating limitations related to the hurricane necessitated an additional outage, which we commenced in late September and successfully completed this month.&#8221; The company's shares fell around 5% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/OLN">low of $39.47</a>.</li>
<li><strong>RSI Value:</strong> 27.97</li>
<li><strong>OLN Price Action:</strong> Shares of Olin fell 0.1% to close at $45.04 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1">breakout in OLN shares</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102524&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="900" height="820" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25081212/image-255.png" alt="" class="wp-image-614271" style="width:671px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25081212/image-255.png 900w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25081212/image-255-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/25081212/image-255-768x700.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></a></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/24/10/41528323/jim-cramer-says-hold-on-to-palantir-let-them-walk-it-up-warns-that-travere-therapeutics-is-losing-a">Jim Cramer Says &#8216;Hold On&#8217; To Palantir, &#8216;Let Them Walk It Up&#8217;; Warns That Travere Therapeutics Is Losing A &#8216;Ton Of Money&#8217;</a></strong></li>
</ul>


Long Ideas

Top 3 Materials Stocks That May Explode In October

WIIM

Olin shares are trading lower after the company reported mixed Q3 financial results. Also, the company said Hurricane Beryl will impact its chemical businesses.

<p>Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $0.03 by 800 percent.  The company reported quarterly sales of $1.59 billion which beat the analyst consensus estimate of $1.57 billion by 0.99 percent.  This is the same as the same period last year.</p>


Earnings Beats

Earnings Misses

Olin Q3 2024 GAAP EPS $(0.21) Misses $0.03 Estimate, Sales $1.59B Beat $1.57B Estimate

Guidance

Olin Sees Q4 2024 Adj. EBITDA $170M-$200M

Olin Says 'Hurricane Beryl impact, we anticipate our Chemical businesses' fourth quarter 2024 adjusted EBITDA to seasonally decline from third quarter 2024.'

<p>Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) will release its quarterly earnings report on Thursday, 2024-10-24. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Olin to report an <strong>earnings per share</strong> (EPS) of $0.08.</p>
<p>The announcement from Olin is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>During the last quarter, the company reported an EPS missed by $0.08, leading to a 7.18% drop in the share price on the subsequent day.</p>
<p>Here's a look at Olin's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.70</td>
<td>0.38</td>
<td>0.19</td>
<td>0.74</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.62</td>
<td>0.40</td>
<td>0.43</td>
<td>0.82</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>1.0%</td>
<td>7.000000000000001%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729695690_0.png" alt="eps graph" /></p>
<h3>Olin Share Price Analysis</h3>
<p>Shares of Olin were trading at $45.76 as of October 22. Over the last 52-week period, shares are down 1.6%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analysts' Perspectives on Olin</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Olin.</p>
<p>With 12 analyst ratings, Olin has a consensus rating of Neutral. The average one-year price target is $51.92, indicating a potential 13.46% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Cabot, Hawkins and Tronox Holdings, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>The consensus outlook from analysts is an Neutral trajectory for Cabot, with an average 1-year price target of $101.5, indicating a potential 121.81% upside.</li>
<li>As per analysts' assessments, Hawkins is favoring an Neutral trajectory, with an average 1-year price target of $122.0, suggesting a potential 166.61% upside.</li>
<li>The consensus among analysts is an Buy trajectory for Tronox Holdings, with an average 1-year price target of $18.5, indicating a potential 59.57% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
<p>In the peer analysis summary, key metrics for Cabot, Hawkins and Tronox Holdings are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Olin</td>
<td>Neutral</td>
<td>-3.45%</td>
<td>$237.80M</td>
<td>3.44%</td>
</tr>
<tr>
<td>Cabot</td>
<td>Neutral</td>
<td>4.96%</td>
<td>$256M</td>
<td>7.96%</td>
</tr>
<tr>
<td>Hawkins</td>
<td>Neutral</td>
<td>1.90%</td>
<td>$64.66M</td>
<td>6.98%</td>
</tr>
<tr>
<td>Tronox Holdings</td>
<td>Buy</td>
<td>3.27%</td>
<td>$150M</td>
<td>0.85%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Olin ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. Olin is at the top for Return on Equity.</p>
<h3>All You Need to Know About Olin</h3>
<p>Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.</p>
<h3>Unraveling the Financial Story of Olin</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Revenue Growth:</strong> Olin's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately <strong>-3.45%</strong>. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.</p>
<p><strong>Net Margin:</strong> Olin's net margin is impressive, surpassing industry averages. With a net margin of <strong>4.51%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>3.44%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Olin's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>0.97%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Olin's debt-to-equity ratio is below the industry average. With a ratio of <b>1.52</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/OLN/earnings"><strong>To track all earnings releases for Olin visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: Olin's Earnings Preview

<p>Across the recent three months, 13 analysts have shared their insights on Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $53.23, a high estimate of $69.00, and a low estimate of $45.00. Highlighting a 14.56% decrease, the current average has fallen from the previous average price target of $62.30. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1728313223_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Olin. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Bhavesh Lodaya</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$50.00</td>
<td>-</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Neutral</td>
<td>$45.00</td>
<td>-</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$51.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$48.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$62.00</td>
<td>$69.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$49.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$49.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$52.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$48.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Announces</td>
<td>Overweight</td>
<td>$55.00</td>
<td>-</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$69.00</td>
<td>$73.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Olin. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Olin compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Olin's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Olin's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/OLN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Olin analyst ratings.</strong></a></p>
<h2>Discovering Olin: A Closer Look</h2>
<p>Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.</p>
<h3>Olin: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Olin faced challenges, resulting in a decline of approximately <strong>-3.45%</strong> in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>4.51%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>3.44%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Olin's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>0.97%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Olin's debt-to-equity ratio is below the industry average. With a ratio of <b>1.52</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Evaluating Olin: Insights From 13 Financial Analysts

<p>Keybanc  analyst Aleksey Yefremov   maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Overweight and lowers the price target from $62 to $57.</p>


Keybanc Maintains Overweight on Olin, Lowers Price Target to $57

Macro Economic Events

Politics

Economics

General

AXON

DGLY

POWW

SWBI

VSTO

WRAP

U.S. Attorney General Garland, 'Devastated' For Families Affected By Shooting, Says FBI, ATF Are On Scene Of Shooting At High School In Georgia; Justice Dept Stands Ready To Provide Resources And Support In Days Ahead

Update: 4 Dead, 30 Injured In Georgia School Shooting

KeyBanc analyst Aleksey Yefremov reiterated a Buy rating on Olin (OLN – Research Report) today and set a price target of $56.00. The company's shar...

KeyBanc Reaffirms Their Buy Rating on Olin (OLN)

Analyst Michael Sison of Wells Fargo maintained a Hold rating on Olin (OLN – Research Report), reducing the price target to $44.00. Michael Sison h...

Olin Corporation: Hold Rating Amidst Earnings Challenges and Potential 2025 Growth

Barclays lowered the firm's price target on Olin (OLN) to $45 from $49 and keeps an Equal Weight rating on the shares post the Q3 report. Most of t...

Olin price target lowered to $45 from $49 at Barclays

Wells Fargo analyst Michael Sison lowered the firm's price target on Olin (OLN) to $44 from $48 to reflect additional estimate cuts. The firm keeps...

Olin price target lowered to $44 from $48 at Wells Fargo

In a report released today, Vincent Andrews from Morgan Stanley maintained a Sell rating on Olin (OLN – Research Report), with a price target of $4...

Morgan Stanley Sticks to Their Sell Rating for Olin (OLN)

RBC Capital lowered the firm's price target on Olin (OLN) to $48 from $52 and keeps an Outperform rating on the shares after its Q3 results. The co...

Olin price target lowered to $48 from $52 at RBC Capital

BMO Capital lowered the firm's price target on Olin (OLN) to $47 from $50 and keeps a Market Perform rating on the shares after its worse than expe...

Olin price target lowered to $47 from $50 at BMO Capital

FBI firearm background checks track higher ahead of the U.S. election

The latest update is out from Olin ( ($OLN) ). Olin Corporation has entered into a $500 million Receivables Purchase Agreement to sell trade receiv...

Olin's New Receivables Purchase Agreement and Financial Shift

The latest announcement is out from Olin ( ($OLN) ). Olin Corporation announced that Dana O'Brien will retire by the end of 2025, stepping down as ...

Olin Announces Leadership Transition with New CLO Appointment

AOUT

SPWH

SSTI

Commodities

Press Releases

Olin Announces First Quarter 2024 Results

Olin Announces New President, Chlor Alkali Products & Vinyls

Olin Among European Union Epoxy Resin Producers Lodging an Anti-Dumping Complaint Against Four Countries

Olin Corporation Second Quarter 2024 Earnings Conference Call Announcement

Olin Corporation Provides Update on Hurricane Beryl

Olin Announces Second Quarter 2024 Results

Olin Corporation to Host Investor Day on December 12, 2024

Olin Corporation Lifts Systemwide Force Majeure for Chlor-Alkali Products

Olin Corporation Third Quarter 2024 Earnings Conference Call Announcement

Olin Announces Third Quarter 2024 Results

AdvanSix

Braskem

Bolt Projects Holdings, Inc. - Common Stock

Bolt Projects Holdings

Cabot

Core Molding Technologies Inc Common Stock

Core Molding Technologies

CN Energy Group Inc. - Class A Ordinary Shares

CN Energy Group

Crown Electrokinetics Corp. - Common Stock

Crown ElectroKinetics

Gulf Resources

Hawkins

Koppers Hldgs

Kronos Worldwide

Loop Industries

Mativ Holdings

Orion

Origin Materials, Inc. - Class A Common Stock

Origin Mat

PureCycle Technologies, Inc. - Common stock

PureCycle Technologies

Tronox Holdings

Trinseo

Westlake

Westlake Chemical Partners LP Common Units representing limited partner interests

Comments

Olin

Vendite allo scoperto

Olin (NYSE:OLN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO